MedPath

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)

Not Applicable
Completed
Conditions
Smoking
Tobacco Use
Interventions
Behavioral: Electronic Cigarette
Registration Number
NCT03453385
Lead Sponsor
Medical University of South Carolina
Brief Summary

The purpose of this study is to measure changes in smoking behavior during and following sampling of an e-cigarette product. E-cigarettes are classified by the US Food and Drug Administration (FDA) as a tobacco product, though they contain no tobacco. Unlike regular cigarettes, which are burned (creating smoke that is inhaled), e-cigarettes include a heating element that vaporizes nicotine. E-cigarettes are likely much safer than conventional cigarettes, but they may not be entirely safe. We are testing the effects of one specific ecigarette (NJoy) on naturalistic changes in smoking behavior. Neither the tobacco industry nor any ecigarette manufacturer provides support of any kind to this study. There is no requirement to quit smoking in this study, nor is there any requirement to use e-cigarettes.

Detailed Description

Eligible smokers, once consented, will be randomized to receive a sample of ecigarettes (NJoy Pre-Filled Tank; n=440) or not (n=220). E-cigarette samples are inclusive of a battery and self-contained tanks of assorted flavors to last up to 4 weeks. Participants will be recruited nationally, but a subset (N=120) will be recruited locally to allow for biomarker collection . Our two-fold purpose is to 1) characterize naturalistic uptake of e-cigarettes, and 2) assess impact of e-cigarette uptake on smoking behavior. All smokers will be asked to provide smoking diary data, captured electronically, daily for 4 weeks. More substantive phone assessment will track smoking and related behaviors at baseline (Day 0) and +10, +17, and +24 days (weekly during initial 3 weeks, following brief lag for delays in product mailing), and at +1, +3, and +6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
638
Inclusion Criteria
  • age 21+,
  • current smoker
  • regular use of email OR capacity to receive SMS text and internet access
  • additional smoking and health criteria determined at screening
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SamplingElectronic CigaretteParticipants will receive an NJOY electronic cigarette to sample and will continue smoking their usual cigarettes as much or as little as they would like.
Primary Outcome Measures
NameTimeMethod
E-cig Use at End of Sampling Periodat week 4

percentage of participants reporting using an e-cigarette

Secondary Outcome Measures
NameTimeMethod
ConversionStudy enrollment through end of 6-month follow up

Percentage of participants who purchase an e-cigarette or additional nicotine liquid on their own

Smoking Cessationat 6-month follow-up

Point prevalence abstinence from conventional smoking

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath